LITTLE SECRETS TRICKLE OUT ABOUT DR YUI, WHO SPOKE OUT ABOUT TURNERS STUDY ON ZICAM.
SEEMS HE FORGOT TO TELL TURNER THAT HE WORKED FOR R. STEVEN DAVIDSON AT GLOBAL CLINICALS
web.archive.org
Welcome to GCI's Scientific Advisory Board
Scientific advisory board consist of some of the finest PhDs and MDs in the country.
Sam Yiu, M.D., Ph.D.
Farshid Sam Rahbar, M.D., F.A.C.P.
Sion Nobel, M.D.
Ernesto Barron, B.S.
==================================================
Ineffectiveness of Intranasal Zinc Gluconate for Prevention of Experimental Rhinovirus Colds
Ronald B. Turner
journals.uchicago.edu
=============================================================
Evaluation of the Efficacy of Intranasal Zinc Gluconate
Samuel C. Yiu
journals.uchicago.edu
===================================================
Reply by Ronald B. Turner to Dr. Yiu
journals.uchicago.edu
========================================
CHIEF EXECUTIVE: R STEVEN DAVIDSON, PRESIDENT
DUNS COMPANY NAME: BIOTEM CYTOTECHNOLOGIES, D.B.A. GLOBAL CLINICAL INC
====================================================
BIOTEM CYTOTECHNOLOGIES February 13, 2004
***THIS DATA IS FOR INFORMATIONAL PURPOSES ONLY***
Copyright 2004 Dun & Bradstreet, Inc.
Federal Employer Identification Numbers
BIOTEM CYTOTECHNOLOGIES
6430 VARIEL AVE STE 102
WOODLAND HLS, CA 91367
TELEPHONE: 818-340-8923
February 13, 2004
LENGTH: 43 words
FEIN: 95-465-3174
CHIEF EXECUTIVE: R STEVEN DAVIDSON, PRESIDENT
DUNS COMPANY NAME: BIOTEM CYTOTECHNOLOGIES, D.B.A. GLOBAL CLINICAL INC
SIC: 87339904
DUNS SOURCE: UNITED STATES DEPT TREASURY - IRS - NON-PROFIT
LANGUAGE: ENGLISH |
